Literature DB >> 11714977

Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells.

Antoine Touzé1, Latifa Bousarghin1, Céline Ster1, Alba-Lucia Combita1, Philippe Roingeard2, Pierre Coursaget1.   

Abstract

The major structural protein (VP1) of the BK polyomavirus (BKV) was expressed in the recombinant baculovirus expression system. Recombinant BKV VP1 was shown to self-assemble into virus-like particles (VLPs) with a diameter of 45-50 nm. As for other polyomaviruses, BKV VP1 has the capacity to bind to exogenous DNA. Furthermore, the potential of BKV VP1 VLPs was investigated for gene transfer into COS-7 cells using three methods for the formation of pseudo-virions: disassembly/reassembly, osmotic shock and direct interaction between VLPs and reporter plasmid DNA. The latter method was shown to be the most efficient when using linearized plasmid. Gene transfer efficiency with BKV pseudo-virions was of the same order as that observed with human papillomavirus type 16 L1 protein VLPs. In addition, it is demonstrated that cellular entry of BKV pseudo-virions is dependent on cell surface sialic acid.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714977     DOI: 10.1099/0022-1317-82-12-3005

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

Review 1.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 2.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

3.  Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies.

Authors:  Antoine Touzé; Julien Gaitan; Françoise Arnold; Raphaël Cazal; Maxime J Fleury; Nicolas Combelas; Pierre-Yves Sizaret; Serge Guyetant; Annabel Maruani; Marc Baay; Mauro Tognon; Pierre Coursaget
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

4.  Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells.

Authors:  Tatyana Voronkova; Andris Kazaks; Velta Ose; Muhsin Ozel; Siegfried Scherneck; Paul Pumpens; Rainer Ulrich
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

5.  Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis.

Authors:  Tatiana Ribeiro; Maxime J Fleury; Enrico Granieri; Massimiliano Castellazzi; Fernanda Martini; Elisa Mazzoni; Pierre Coursaget; Mauro Tognon
Journal:  Neurol Sci       Date:  2010-06-15       Impact factor: 3.307

6.  Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Authors:  Alba-Lucia Combita; Antoine Touzé; Latifa Bousarghin; Neil D Christensen; Pierre Coursaget
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.

Authors:  Subrat Kumar Panda; Neeraj Kapur; Daizy Paliwal; Hemlata Durgapal
Journal:  J Nanobiotechnology       Date:  2015-06-24       Impact factor: 10.435

8.  Construction of a Baculovirus vector containing A subunit of Shiga toxin for protein delivery.

Authors:  Mana Oloomi; Saeid Bouzari; Maryam Imani; Narges Akhtarian
Journal:  Iran J Microbiol       Date:  2013-12

9.  High cooperativity of the SV40 major capsid protein VP1 in virus assembly.

Authors:  Santanu Mukherjee; Mahmoud Abd-El-Latif; Michal Bronstein; Orly Ben-nun-Shaul; Stanislav Kler; Ariella Oppenheim
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

10.  Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort.

Authors:  R Newton; T Ribeiro; D Casabonne; E Alvarez; A Touzé; T Key; P Coursaget
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.